Headquartered in Woonsocket, RI Fiscal year ends December NYSE: CVS cvshealth.com
CVS Health Corporation (NYSE: CVS) is a health solutions company operating through three primary segments: Health Care Benefits (Aetna), which offers insured and self-insured medical, pharmacy, dental and behavioral health products serving approximately 26 million medical members and an estimated 37 million people through health insurance products; Health Services (Caremark), which provides pharmacy benefit management solutions serving approximately 87 million plan members, delivers health care services through medical clinics, virtual care, and in-home settings, and offers provider enablement solutions; and Pharmacy & Consumer Wellness, which operates approximately 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care medical clinics (including MinuteClinic), dispensing prescriptions, providing vaccination administration, and selling health and wellness products. The company's integrated model connects pharmacy benefits management, health insurance, and retail pharmacy to deliver technology-driven, personalized health care services. CVS Health is deploying agentic AI across its Aetna and Caremark businesses and has launched comprehensive GLP-1 support programs across its pharmacy and clinic network. Updated
On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE:UNH | UNH Price Prediction): “If you have…
Jim Cramer sees three stocks with very different amounts of bad news or good news already baked into their prices, and figuring out which side each sits on changes everything about whether…
A lymphoma patient on Medicaid can face four separate insurance permission slips before her first treatment begins, and every one of those gates is a chance for her care to stall. Aetna…
Gerelyn Terzo CVS trades at a forward multiple that screams cheap, yet the street's already bullish and our model runs even hotter. Before you trust either read, there are a few risks that could…
Trey Thoelcke The shingles vaccine costs nothing under Medicare Part D, yet thousands of beneficiaries walk out of their doctor's office owing hundreds of dollars for the exact same shot. The billing system has…
Both CVS and Intel delivered real turnaround results in 2026, then both stocks got punished for very different reasons. For a retiree drawing income from a portfolio, one of those reasons matters…
Mark Cuban says AI will never replace radiologists, and his reasoning has nothing to do with capability. The real disruption, he argues, targets a different layer of medicine entirely, one worth hundreds…
When a hospital walks out of a Medicare Advantage contract, the member left behind faces a narrower set of protections and a much higher potential bill than most people realize until the…
Gerelyn Terzo Hims and Hers has 2.6 million subscribers, a battered stock price, and a CEO buying shares instead of signaling an exit. That combination puts a very specific list of giants on alert,…
Millions of Medicare Advantage members will open a letter this fall that could quietly close doors they assume will always stay open. What insurers have already decided for 2027 and what enrollees…
CVS Health stock has surged nearly 80% in a year while the quarterly dividend has sat frozen for ten straight quarters, raising a pointed question for income investors: is this pause a…
Trey Thoelcke Healthcare is quietly stealing the spotlight from mega cap tech in 2026, and two S&P 500 giants are trading at valuations that suggest the market has not caught on yet.
Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS | CVS Price Prediction) as the consolidation winner in a…
The S&P 500 keeps climbing, up nearly 9% year to date, and yet a handful of large-cap dividend payers are trading like the bull market forgot they exist. That is exactly where…
The Pacer US Cash Cows 100 ETF (CBOE:COWZ) is having a solid 2026, up 6.4% year to date and 14.81% over the past year through July 6. Yet a fund built expressly…
CVS Health Corporation (NYSE: CVS) is a health solutions company operating through three primary segments: Health Care Benefits (Aetna), which offers insured and self-insured medical, pharmacy, dental and behavioral health products serving approximately 26 million medical members and an estimated 37 million people…
24/7 Wall St.'s 12-month price target for CVS is $131.04, rated Buy. The Wall Street consensus target is $115.76. CVS price prediction →
